AngioWave

AngioWave is a healthcare technology company that develops AI-powered, post-processing medical technology to enhance the visualization of vascular structures during angiographic procedures. The company's core product, AngioWaveNet, is software that automatically processes radiological images to help clinicians analyze them more efficiently. This platform integrates with existing fluoroscopic angiography systems to provide clearer imaging, which assists cardiologists in diagnosing conditions like coronary artery disease more effectively and with a lower radiation dose.

The company's technology is designed to improve clinical decision-making and patient outcomes by offering a minimally invasive approach. It has been involved in clinical trials to evaluate radiation reduction in heart imaging procedures. Founded in 2020, AngioWave is a private company backed by institutional investor DRADS Capital and has raised at least $8.33M in funding. The company's focus is on aiding cardiologists and patients with symptomatic peripheral artery disease (PAD) by improving blood flow through the stimulation of new blood vessel growth and removal of micro-plaque.

Keywords: medical imaging, artificial intelligence, radiology AI, angiographic procedures, vascular visualization, coronary artery disease, fluoroscopic angiography, clinical decision support, peripheral artery disease, healthcare technology, medical device, low-radiation imaging, cardiology, cardiovascular health, image processing software, diagnostic imaging, interventional cardiology, plaque analysis